A new pilot program from the federal government has hospital and pharmacy leaders bracing for what they describe as a fundamental dismantling of the ...
If HHS' 340B rebate model pilot proceeds as planned, more than 2,700 U.S. hospitals will collectively be saddled with approximately $400 million ...
AHA comments on the Health Resources and Services Administration’s (HRSA) information collection request (ICR) regarding the expected costs of its 340B Rebate Model Pilot Program.
1don MSN
Reform of federal drug discount program should target misaligned incentives, researchers say
The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers.
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program’s ...
Hospitals and major drugmakers are battling over the financial impact of a government pilot program that could shake up how ...
Americans assume hospitals are in the business of keeping us healthy, not of buying drugs inexpensively and then reselling ...
The White House has proposed good and bad ideas to reduce drug costs. Among the better ones is a reform of the obscure 340B ...
The following information was released by the National Pharmaceutical Council:. Washington, D.C. The 340 B Drug Pricing Program has grown immensely since the Affordable Care Act was passed in 2010.
The nonpartisan scorekeeper’s new report reinforces longstanding concerns about the 340B drug discount program, including that it incentivizes behaviors that increase health costs for federal and ...
Investments in Uncompensated Care and Vulnerable Populations Have Decreased on Average While Hospital Investments in Financial Portfolios Have Ballooned A new analysis of 340B hospital data found that ...
The vast majority of hospitals that participate in the 340B drug pricing program do not follow recent hospital transparency regulations requiring them to report the prices they charge for oncology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback